Mode
Text Size
Log in / Sign up

Prolonged prone positioning shows oxygenation benefit but inconclusive mortality effect in COVID-19 ARDSLonger prone positioning may improve oxygen levels in COVID-19 ARDS patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret improved oxygenation with prolonged prone positioning cautiously, as mortality benefit is unconfirmed and pressure injury risk may increase.

This systematic review, meta-analysis, and trial-sequential analysis evaluated the clinical benefits of prolonged versus standard prone positioning in adult patients with coronavirus disease 2019 (COVID-19) and moderate-to-severe acute respiratory distress syndrome (ARDS). The analysis pooled data from 996 patients across seven studies, comprising 592 patients in the prolonged positioning group and 404 in the standard positioning group. The included studies were six observational studies and one randomized controlled trial (RCT). The specific clinical setting and follow-up duration were not reported. The intervention was defined as prolonged prone positioning with a mean session duration greater than 24 hours, compared to a standard protocol with mean session durations of 24 hours or less. The analysis did not provide further details on the specific dosing protocols, frequency of sessions, or criteria for initiation and cessation of prone positioning in either group.

The primary outcomes were mortality and the incidence of pressure injuries. For mortality, the analysis found a non-significant trend toward lower mortality with prolonged positioning. The relative risk (RR) was 0.81, with a 95% confidence interval (CI) of 0.60 to 1.09 (P = 0.16). In absolute terms, the mortality rate was 33.8% in the prolonged group versus 39.8% in the standard group. For pressure injuries, there was a borderline significant increase associated with prolonged positioning. The RR was 1.27 (95% CI: 1.00 to 1.62; P = 0.05), with an absolute incidence of 30.2% in the prolonged group compared to 26.2% in the standard group.

Key secondary outcomes included intensive care unit (ICU) length of stay, respiratory parameters, and oxygenation. There was no significant difference in ICU length of stay between groups, with a mean difference of 2.74 days favoring the standard group (P = 0.13). Specific absolute numbers for this outcome were not reported. The analysis found no significant differences in positive end-expiratory pressure or driving pressure between the two strategies; specific effect sizes and data were not reported. However, oxygenation showed significant improvements with prolonged positioning. During prone positioning, the partial pressure of arterial oxygen-to-fraction of inspired oxygen (PaO2/FiO2) ratio improved by a mean difference (MD) of 17.42 mmHg (P = 0.003). After prone positioning, the PaO2/FiO2 ratio improvement was even greater, with an MD of 23.83 mmHg (P = 0.008). Absolute numbers for these oxygenation outcomes were not reported.

Detailed safety and tolerability findings were not reported in the analysis. The provided data does not include rates of adverse events, serious adverse events, or treatment discontinuations specifically related to the prone positioning protocols. The borderline increase in pressure injuries (RR 1.27) represents the only quantifiable safety signal from the reported outcomes.

These results add to a complex body of evidence on prone positioning in ARDS. Prior landmark studies, such as the PROSEVA trial, established the mortality benefit of prone positioning (sessions of at least 16 hours) in severe ARDS, but primarily in non-COVID populations. This meta-analysis specifically in COVID-19 ARDS suggests a physiological benefit (improved oxygenation) with longer sessions, but it does not replicate the clear mortality benefit seen in earlier research. The findings highlight that the optimal duration and patient population for prone positioning in COVID-19-related ARDS may differ from general ARDS management.

The analysis has several key methodological limitations. The evidence base is predominantly observational (six of seven studies), which limits the ability to establish causality and increases susceptibility to confounding and selection bias. The single included RCT limits the strength of the conclusions. Furthermore, the trial-sequential analysis performed indicated that the current cumulative evidence is insufficient to confirm or refute a benefit or harm regarding mortality, meaning the sample size is inadequate for a definitive conclusion. Heterogeneity in patient management, prone positioning protocols, and definitions of outcomes across the seven included studies may also affect the consistency of the pooled results.

For clinical practice, these findings suggest that while prolonged prone positioning (>24 hours per session) in COVID-19 ARDS is associated with significantly better oxygenation parameters compared to standard duration, this physiological improvement did not translate into a statistically significant mortality reduction in this analysis. Clinicians should note the borderline increased risk of pressure injuries with prolonged sessions. Decisions on prone positioning duration should therefore balance the potential for improved gas exchange against the practical challenges and skin injury risks of very prolonged sessions, recognizing that the evidence for a net clinical benefit remains inconclusive.

Important questions remain unanswered. It is unclear if specific subgroups of COVID-19 patients with ARDS (e.g., defined by severity, comorbidities, or timing) might derive a mortality benefit from prolonged positioning. The optimal protocol for prolonged sessions—including exact duration, frequency, and criteria for cessation—requires definition through prospective RCTs. The impact of prolonged positioning on other important clinical outcomes, such as ventilator-free days, long-term functional status, and specific safety events beyond pressure injuries, is not addressed by this analysis and warrants further investigation.

This research matters to people who have been critically ill with COVID-19 and their families. During the pandemic, many patients with severe lung failure, called acute respiratory distress syndrome (ARDS), needed a breathing machine. A common treatment was 'prone positioning'—carefully turning patients onto their stomachs to help their lungs work better. Doctors have debated whether keeping patients in this position for longer periods is more helpful. This review aimed to find an answer by looking at all the available research, which could help guide care for future patients with similar severe lung conditions.

The researchers conducted a systematic review and meta-analysis, which means they carefully searched for and combined the results of all relevant studies on this topic. They focused on adult COVID-19 patients with moderate-to-severe ARDS who were on breathing machines. In total, they analyzed data from 996 patients across seven studies. Of these patients, 592 received 'prolonged' prone positioning, where the average session lasted more than 24 hours. The other 404 received 'standard' prone positioning, with sessions lasting 24 hours or less. It's important to note that six of the seven studies were observational, meaning researchers watched and recorded what happened in real-world care, rather than actively assigning patients to different groups in a controlled experiment. Only one was a randomized controlled trial, which is considered the strongest type of evidence.

The analysis found several key results. First, there was a non-significant trend suggesting that longer prone sessions might be linked to lower mortality. The death rate was about 34% in the prolonged group versus 40% in the standard group. However, the statistical analysis showed this difference could easily be due to chance, so it cannot be considered a proven benefit. More clearly, oxygen levels improved significantly during and after the longer prone sessions. On average, a key measure of oxygen in the blood was about 17 to 24 points higher in the prolonged group, which is a meaningful short-term improvement for the lungs. On the safety side, there was a borderline significant increase in pressure injuries (like bedsores) with longer positioning—about 30% of patients in the prolonged group experienced them compared to 26% in the standard group. There were no clear differences in how long patients stayed in the ICU or in other breathing machine settings.

The most important caveat is that the evidence remains inconclusive. The researchers performed a 'trial sequential analysis,' a statistical method that checks if enough patients have been studied to draw a firm conclusion. This analysis confirmed that the current total evidence is insufficient to reliably confirm either a benefit or a harm from prolonged prone positioning. The findings, especially the trend in mortality, need to be viewed with great caution because most of the data comes from observational studies. In such studies, other factors besides prone positioning time could explain the differences in outcomes. The single randomized trial included was not large enough to settle the question on its own.

Regarding safety, the main concern noted was the potential increase in pressure injuries. Turning critically ill patients requires a skilled team to prevent complications like skin breakdown, nerve injuries, or accidental tube dislodgement. While this review specifically highlighted pressure injuries, the general risks of prone positioning are well-known to ICU teams. The analysis did not report on other specific adverse events, serious adverse events, or how many patients could not tolerate the procedure, which is a limitation.

What does this mean for patients right now? For individuals currently in the hospital, decisions about prone positioning—including how long each session lasts—will continue to be made carefully by the intensive care team based on the specific patient's condition, hospital protocols, and the latest guidelines. This review does not provide definitive proof to change standard practice. It suggests that longer sessions might offer a lung oxygenation advantage, but with a potential trade-off of more skin injuries. It strongly highlights the need for more high-quality, randomized controlled trials to get a clearer answer. For now, this research adds a piece to the ongoing medical discussion but is not a practice-changing conclusion.

What this means for you:
Longer prone positioning may boost oxygen levels but might increase skin sores; more research is needed for clear answers.

Study Details

Study typeMeta analysis
Sample sizen = 2,019
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
OBJECTIVES: The optimal duration of prone positioning for improving outcomes in acute respiratory distress syndrome remains uncertain. This meta-analysis compared clinical outcomes of prolonged versus standard prone positioning in adult coronavirus disease 2019 patients with moderate-to-severe acute respiratory distress syndrome. METHODS: PubMed, SCOPUS, and Cochrane databases were systematically searched for randomised controlled trials (RCTs) and observational studies. Prolonged prone positioning was defined as a mean duration >24 h per session and standard as ≤ 24 h. Outcomes included mortality, pressure injuries, oxygenation, and respiratory parameters. A trial sequential analysis was conducted for mortality and pressure injuries. RESULTS: Seven studies (six observational and one RCT) involving 996 patients (592 prolonged and 404 standard) were included in the study. Prolonged prone positioning showed a nonsignificant trend towards lower mortality (33.8% vs. 39.8%, RR: 0.81, 95% confidence interval: 0.60-1.09; P = 0.16) and a borderline increase in pressure injuries (30.2% vs. 26.2%; relative risk (RR) 1.27, 95% confidence interval: 1.00-1.62; P = 0.05). The trial sequential analysis indicated that current evidence is insufficient to confirm benefit or harm. No significant differences were observed in intensive care unit length of stay (mean difference [MD]: 2.74 days; P = 0.13) or changes in positive end-expiratory pressure or driving pressure in both groups. Oxygenation improved significantly during (partial pressure of arterial oxygen-to-fraction of inspired oxygen ratio MD: 17.42 mmHg; P = 0.003) and after prone positioning (partial pressure of arterial oxygen-to-fraction of inspired oxygen ratio MD: 23.83 mmHg; P = 0.008). CONCLUSION: Prolonged prone positioning was associated with trends towards lower mortality and higher frequency of pressure injury risk, but evidence remains inconclusive. While oxygenation improved, clinical outcomes of intensive care unit length of stay and respiratory parameters were unchanged. Additional high-quality RCTs are needed to clarify the balance of benefits and risks and guide future recommendations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.